BiomX (NYSEMKT:PHGE) just reported results for the fourth quarter of 2023. BiomX reported earnings per share of -8 cents. The company did not report any revenue for the quarter. InvestorPlace ...

BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in ...